Services
Expertises
Resources
Who we are
Canadian personalized medicine R&D partnering mission to Germany – October 17-21, 2022 - Canada
Closed
Source verified July 8, 2026

Canadian personalized medicine R&D partnering mission to Germany – October 17-21, 2022

R&D partnering mission for Canadian SMEs
Funding available
Varies by project
Deadline
September 9, 2022
Location
Canada
Who can apply

Small and medium-sized enterprises

See full eligibility

Overview

Canadian personalized medicine R&D partnering mission to Germany – October 17-21, 2022 was open to small and medium-sized enterprises seeking personalized medicine partnering opportunities in Germany. Technologies of interest included biologics and advanced therapies, antibody-based therapeutics and other targeted biologics, and lipid nanoparticle platforms with genetic medicine payloads such as mRNA, siRNA, and CRISPR.
/100
Opportunity Score
Moderate potential, but conditions must align.

At a glance

Funding available

Financing goals
  • Develop strategic partnerships
  • Conduct research and development activities
  • Access new markets
Eligible Funding
  • Varies by project

Eligible candidates

Eligible Industries
  • All industries
Location
  • Canada
Legal structures
  • All legal structures
Annual revenue
  • All revenue ranges
Organisation size
  • All organization sizes
Audience
  • All groups

Next Steps

1
Determine your project
2
Validate your eligibility

Official resources

Official page

Canadian personalized medicine R&D partnering mission to Germany - October 17-21, 2022

Eligibility

Who is eligible?

  • Small and medium-sized enterprises

Additional information

  • The page is archived and will not be updated.
  • Technologies and products of particular interest include biologics and advanced therapies, antibody-based therapeutics and other targeted biologics, advanced therapies such as cell and gene therapies, CAR-T cells and tissue engineered therapies, and lipid nanoparticle platforms with genetic medicine payloads such as mRNA, siRNA and CRISPR.

Contacts

Other components of this program

Explore related funding streams and grants that belong to the same program.

Frequently Asked Questions about the Canadian personalized medicine R&D partnering mission to Germany – October 17-21, 2022 Program

What is the Canadian personalized medicine R&D partnering mission to Germany – October 17-21, 2022?

Canadian personalized medicine R&D partnering mission to Germany – October 17-21, 2022 was open to small and medium-sized enterprises seeking personalized medicine partnering opportunities in Germany. Technologies of interest included biologics and advanced therapies, antibody-based therapeutics and other targeted biologics, and lipid nanoparticle platforms with genetic medicine payloads such as mRNA, siRNA, and CRISPR.

Who is eligible for the Canadian personalized medicine R&D partnering mission to Germany – October 17-21, 2022 program?

To be eligible for the Canadian personalized medicine R&D partnering mission to Germany – October 17-21, 2022 program, you must: Small and medium-sized enterprises

Who can I contact for more information about the Canadian personalized medicine R&D partnering mission to Germany – October 17-21, 2022?

You can contact National Research Council Canada (NRC) by email at none or by phone at none.

Where is the Canadian personalized medicine R&D partnering mission to Germany – October 17-21, 2022 available?

The Canadian personalized medicine R&D partnering mission to Germany – October 17-21, 2022 program is available across Canada.

Is the Canadian personalized medicine R&D partnering mission to Germany – October 17-21, 2022 a grant, loan, or tax credit?

Canadian personalized medicine R&D partnering mission to Germany – October 17-21, 2022 is a Partnering and Collaboration

Who are the financial supporters of the Canadian personalized medicine R&D partnering mission to Germany – October 17-21, 2022?

Canadian personalized medicine R&D partnering mission to Germany – October 17-21, 2022 is funded by National Research Council Canada (NRC)